COVID-19 infections fell significantly – by 65% percent – after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech
The FINANCIAL -- Data from the COVID-19 Infection Survey, a partnership between the University of Oxford, the Office of National Statistics ...
